Some patients explore glutathione supplementation to support cellular antioxidant defenses, though clinical evidence for this specific pairing remains limited
For employers, this part of their obesity care strategy stays the same: lifestyle support continues to be essential
Semaglutide is FDA-approved for type 2 diabetes management (Ozempic, Rybelsus), cardiovascular risk reduction in patients with type 2 diabetes and established cardiovascular disease (Ozempic), chronic weight management in obesity or overweight with comorbidities (Wegovy), and cardiovascular risk reduction in adults with established cardiovascular disease and obesity or overweight (Wegovy)
They work through different receptor pathways (amylin and GLP-1 respectively) and are injected separately at different sites on the same day
ColonBroom GLP-1 Booster is not a magic bullet, but it's not meant to be
Compounded GLP-1 programs, manufacturer savings cards, and cash-pay telehealth clinics have opened up real alternatives